Literature DB >> 10513771

Relation between systemic hypertension and blood lipids on the risk of myocardial infarction.

J M Gaziano1, H D Sesso, J L Breslow, C H Hennekens, J E Buring.   

Abstract

We sought to evaluate the potential interactions between systemic hypertension and blood lipids on the risk of myocardial infarction (MI). Recent evidence suggests that hypertension may interact with other risk factors such as dyslipidemia in the development of coronary heart disease. However, the precise nature of that interrelation remains unclear. We selected 340 cases of first MI and an equal number of age-, sex-, and community-matched controls. Data were collected on a large number of coronary risk factors, and fasting blood samples were obtained. Logistic regression was used to calculate the odds ratio (OR) of nonfatal MI. The age- and sex-adjusted OR of MI was 1.61 (95% confidence interval [CI] 1.15 to 2.25) among treated hypertensives compared with nonhypertensives. Further adjustment for coronary risk factors did not materially alter the results (OR 1.67, 95% CI 1.16 to 2.41). To explore the interrelations among hypertension, lipids, and risk of MI, each lipoprotein parameter was individually added to the risk factor-adjusted multivariate model. The apparent risk associated with hypertension was substantially attenuated by the addition of either high-density lipoprotein cholesterol (OR 1.25, 95% CI 0.82 to 1.90) or triglycerides (OR 1.37, 95% CI 0.91 to 2.05). No significant interactions were found between hypertension and any lipoprotein parameter. These data indicate that the risk of MI associated with treated hypertension may have a lipid mechanism involving high-density lipoprotein cholesterol and/or triglycerides.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10513771     DOI: 10.1016/s0002-9149(99)00435-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Differences in Lipid Profiles and Atherogenic Indices Between Hypertensive and Normotensive Populations: A Cross-Sectional Study of 11 Chinese Cities.

Authors:  Wenke Cheng; Lili Wang; Siwei Chen
Journal:  Front Cardiovasc Med       Date:  2022-05-17

Review 2.  Relationships among insulin resistance, type 2 diabetes, essential hypertension, and cardiovascular disease: similarities and differences.

Authors:  Gerald M Reaven
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-04       Impact factor: 3.738

3.  Impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: results from the ICEBERG study.

Authors:  Giray Kabakci; Nevres Koylan; Baris Ilerigelen; Omer Kozan; Kemalettin Buyukozturk
Journal:  Integr Blood Press Control       Date:  2008-11-02

4.  The Mechanism Research of Qishen Yiqi Formula by Module-Network Analysis.

Authors:  Shichao Zheng; Yanling Zhang; Yanjiang Qiao
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-24       Impact factor: 2.629

5.  Changes in lipids and lipoprotein indices in relation to the severity of hypertension in newly diagnosed hypertensive nigerians.

Authors:  E I Onwubuya; B C Anisiuba; C U Osuji; J E Ahaneku
Journal:  ISRN Cardiol       Date:  2012-12-11

6.  Formulation and evaluation of fixed-dose combination of bilayer gastroretentive matrix tablet containing atorvastatin as fast-release and atenolol as sustained-release.

Authors:  Sanjay Dey; Sankha Chattopadhyay; Bhaskar Mazumder
Journal:  Biomed Res Int       Date:  2014-01-02       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.